Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
194.9 USD | +0.76% | -2.37% | -14.25% |
May. 30 | JPMorgan Adjusts Price Target on Laboratory Corp of America Holdings to $243 From $261 | MT |
May. 23 | Some of the biggest splits in Corporate America | RE |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analyst opinion has improved significantly over the past four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company is not the most generous with respect to shareholders' compensation.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-14.25% | 16.43B | B | ||
+25.52% | 88.99B | C+ | ||
-24.52% | 74.82B | B- | ||
-5.56% | 25.03B | C+ | ||
+4.31% | 17.88B | A- | ||
+2.97% | 15.77B | A- | ||
+70.11% | 13.09B | C- | ||
+79.20% | 13.21B | C+ | ||
+40.44% | 12.9B | B- | ||
+24.51% | 12.7B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- LH Stock
- Ratings Labcorp Holdings Inc.